AMBOSS
About AMBOSS
AMBOSS is a comprehensive digital medical knowledge platform designed by physicians, for physicians, to support medical professionals throughout their entire career journey. It serves as an indispensable resource for both medical students and practicing clinicians, integrating a vast medical library with over 22,000 exam-style questions and intelligent clinical and educator tools. For students, AMBOSS provides an interactive learning experience and high-yield question bank crucial for excelling in exams such as the USMLE, COMLEX, Shelf Exams, and various board certifications including ABIM, ABFM, ABP, and ABEM.
For clinicians, AMBOSS functions as a powerful digital co-pilot for everyday clinical practice. It offers precise, evidence-based, and actionable recommendations on diagnostics and treatment, guided by the latest medical guidelines. The platform’s Clinical Care features include management checklists, differential diagnoses, drug dosing, clinical calculators, and a comprehensive clinical drug database, all designed to streamline workflows, save time, and minimize treatment errors. Leveraging innovative AI-powered technology, AMBOSS ensures that medical knowledge is not only accurate and accessible but also dynamically presented to support critical decision-making at the point of care.
AMBOSS is trusted by over a million healthcare professionals across more than 180 countries and is adopted by numerous medical schools and hospital groups worldwide as a foundational medical reference. The company is committed to empowering all doctors to provide the best possible care by continuously combining trusted medical content with cutting-edge technology, and has recently expanded its offerings to include nurses and other healthcare professionals.
Focus Areas
Business Intelligence
| Key Investors | KIRKBI, M&G Investments, Lightrock, Partech, Project A Ventures, Burda Principal Investments (BPI), Quadrille Capital, Target Global, Cherry Ventures, Wellington Partners, StillMark, Castle Island Ventures, Draper Associates, Fulgur Ventures, Ride Wave Ventures, Valor Equity Partners, Omri Benayoun, Christian Meermann, Holtzbrinck Digital, Atomico |
| Partnerships | Helios (Europe's largest hospital group), American Medical Association (AMA), NEJM Group (for content integration and Master Classes in Medicine), DGPA (for PA-studium in Germany) |
| Acquisitions | Novaheal (2024), NEJM Knowledge+ (2024) |
| Technology | AI-empowered technology, cloud-native digital platform, AI-powered search agent (AMBOSS AI Mode/LiSA 1.0), AI Assistants (beta), AMBOSS Mapped, Model Context Protocol (MCP) for AI integration, evidence-based content curation by physicians |
What Physicians Need to Know
For physicians, AMBOSS is a powerful tool for both continuous learning and immediate clinical application. Leverage the 'Clinician Mode' for quick access to management checklists, differential diagnoses, and drug information at the point of care, even offline. Utilize the AI Mode Clinical Care to efficiently navigate evidence and support your independent clinical judgment, knowing it draws from curated, clinically validated sources. For board recertification or longitudinal knowledge assessments, the extensive Qbanks are invaluable. Integrate AMBOSS with your Anki workflow and use the Chrome extension to maximize efficiency in your daily study and practice.
AMBOSS offers key integrations to streamline workflows, including an Anki add-on for enhanced flashcard learning, a Chrome browser extension for quick lookups, and integrations with GPT for advanced AI functionalities.
What the Web Says
AMBOSS is a highly-regarded medical learning and reference platform, particularly popular among medical students and residents for USMLE, COMLEX, and NBME Shelf exam preparation. Reviewers consistently praise its comprehensive medical content, user-friendly interface, and interactive learning tools. While generally seen as a strong alternative or complement to UWorld, some users find its questions overly difficult or convoluted. The company itself receives positive feedback for its culture and supportive environment, though some express concerns about career development.
Overall: PositiveStrengths
- Comprehensive medical content and knowledge library.
- Effective for exam preparation (USMLE, COMLEX, NBME Shelf exams).
- Excellent Anki add-on and integration.
- User-friendly interface and interactive learning tools.
- High-quality explanations and diagrams.
- Good work-life balance and positive company culture (employer reviews).
Limitations
- Subscription cost can be high.
- Some questions are considered overly difficult or esoteric.
- Occasional content update lags.
- Limited specialty coverage in some areas (e.g., dermatology, rare diseases).
- Lack of offline access for some features.
- Concerns about career development/advancement (employer reviews).
Based on reviews from: Reddit, Apple App Store, WorthEPenny, Quora, Indeed.com, MedEd University
Last updated: 2026-07-28
Videos
News, demos, and interviews about AMBOSS.
Videos load interactively. If none appear, search YouTube for AMBOSS →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded AMBOSS.
Comparisons
When choosing between iatroX and AMBOSS, physicians should consider their primary needs: quick, free access to UK-specific guidance and exam prep, or a comprehensive, paid global medical knowledge and Qbank platform with HIPAA compliance. Both tools offer AI-powered clinical decision support and medical education features, but their core strengths and target users differ significantly. iatroX […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]